Laurion Capital Management LP Mirum Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $808,785 - $1.21 Million	-43,908 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $680,574 - $1.05 Million	43,908 New	43,908 $967,000
Q1 2021 May 14, 2021	SELL	$16.29 - $21.92 $680,922 - $916,256	-41,800 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.75 - $25.45 $658,350 - $1.06 Million	41,800 New	41,800 $730,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.